Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts

Rezolute, Inc. (NASDAQ:RZLT) has been given an average rating of “Buy” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have covered the stock in the last year is $11.57.

Several analysts recently issued reports on RZLT shares. JMP Securities reaffirmed a “market outperform” rating and set a $7.00 price objective on shares of Rezolute in a research note on Friday, September 20th. Guggenheim started coverage on shares of Rezolute in a research note on Tuesday, August 27th. They issued a “buy” rating and a $11.00 price target for the company. BTIG Research increased their price target on shares of Rezolute from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Tuesday, September 10th. Maxim Group increased their price target on shares of Rezolute from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Finally, HC Wainwright reissued a “buy” rating and issued a $14.00 price target on shares of Rezolute in a research note on Friday, September 27th.

Hedge Funds Weigh In On Rezolute

Several large investors have recently made changes to their positions in RZLT. Cubist Systematic Strategies LLC lifted its holdings in Rezolute by 366.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 54,237 shares of the company’s stock worth $233,000 after buying an additional 42,597 shares in the last quarter. Affinity Asset Advisors LLC raised its holdings in shares of Rezolute by 15.6% in the 2nd quarter. Affinity Asset Advisors LLC now owns 1,850,000 shares of the company’s stock valued at $7,955,000 after purchasing an additional 250,000 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Rezolute in the 2nd quarter valued at $4,503,000. XTX Topco Ltd raised its holdings in shares of Rezolute by 205.8% in the 2nd quarter. XTX Topco Ltd now owns 33,671 shares of the company’s stock valued at $145,000 after purchasing an additional 22,660 shares in the last quarter. Finally, Dimensional Fund Advisors LP acquired a new stake in shares of Rezolute in the 2nd quarter valued at $255,000. 82.97% of the stock is currently owned by institutional investors and hedge funds.

Rezolute Trading Up 0.4 %

Shares of NASDAQ RZLT opened at $5.50 on Friday. Rezolute has a 12-month low of $0.72 and a 12-month high of $6.10. The stock has a market cap of $307.62 million, a PE ratio of -4.14 and a beta of 1.18. The company has a 50-day moving average of $4.96 and a 200 day moving average of $4.32.

Rezolute (NASDAQ:RZLT) last announced its quarterly earnings data on Thursday, September 19th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.14). On average, sell-side analysts forecast that Rezolute will post -1.23 EPS for the current fiscal year.

About Rezolute

Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.